Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200971 | 1.00 | SNCA (0.49) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Iodide SCHEMBL10580297 | 0.99 | SNCA (0.48) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL75983 | 0.95 | SNCA (0.48) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL4755956 | 0.95 | SNCA (0.48) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Water SCHEMBL9843599 | 0.94 | SNCA (0.47) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7922534 | 0.94 | SNCA (0.47) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Naphthalene SCHEMBL9806048 | 0.93 | SNCA (0.46) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Water SCHEMBL10771784 | 0.93 | SNCA (0.46) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Naphthalene SCHEMBL16150068 | 0.92 | SNCA (0.45) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Anthracene SCHEMBL3834018 | 0.91 | SNCA (0.44) | SNCAHDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4155397-B1 | DETECTION OF NUCLEIC ACIDS | UNIV MICHIGAN REGENTS (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240036035-A1 | ANALYTE DETECTION USING FLUOROGENIC PROBES OR MULTIPLEX TECHNOLOGIES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-02-01 | — | — | US | disclosed |
| WO-2024015860-A2 | ANALYTE DETECTION USING FLUOROGENIC PROBES OR MULTIPLEX TECHNOLOGIES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024015927-A2 | ANALYTE DETECTION USING APTAMERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20230159611-A1 | SMALL MOLECULE ADAPTER REGULATED, TARGET SPECIFIC CHIMERIC ANTIGEN RECEPTOR BEARING T CELLS (SMART CARS) | YALE UNIVERSITY | 2023-05-25 | — | — | US | disclosed |
| EP-4155397-A1 | DETECTION OF NUCLEIC ACIDS | The Regents of The University of Michigan (US) | 2023-03-29 | — | — | EP | disclosed |
| US-20230070399-A1 | METHODS AND SYSTEMS FOR PROCESSING TIME-RESOLVED SIGNAL INTENSITY DATA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-03-09 | — | — | US | disclosed |
| EP-4121556-A1 | ANALYTE DETECTION | The Regents of The University of Michigan (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-115516107-A | Analyte detection | 密歇根大学董事会 | 2022-12-23 | — | — | CN | disclosed |
| EP-4105338-A1 | DETECTION OF NUCLEIC ACIDS | The Regents of The University of Michigan (US) | 2022-12-21 | — | — | EP | disclosed |
| EP-1368460-A2 | REAL-TIME SEQUENCE DETERMINATION | Visigen Biotechnologies, Inc. (US) | 2003-12-10 | — | — | EP | disclosed |
| WO-2003048868-A1 | APPARATUS AND METHOD FOR DIGITAL HOLOGRAPHIC IMAGING | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2003-06-12 | — | — | WO | disclosed |
| US-20030064366-A1 | Real-time sequence determination | Life Technologies Corporation | 2003-04-03 | — | — | US | disclosed |
| WO-2001062952-A9 | METHODS FOR DETERMINING SINGLE NUCLEOTIDE VARIATIONS | DNA SCIENCES INC (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002004680-A2 | REAL-TIME SEQUENCE DETERMINATION | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2002-01-17 | — | — | WO | disclosed |
| US-20010049102-A1 | Methods for determining single nucleotide variations | DNA SCIENCES, INC. | 2001-12-06 | — | — | US | disclosed |
| WO-2001062952-A1 | METHODS FOR DETERMINING SINGLE NUCLEOTIDE VARIATIONS | DNA SCIENCES, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| US-5270548-A | Phase-sensitive flow cytometer | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1993-12-14 | — | — | US | disclosed |
| US-5206143-A | Method and reagents for performing subset analysis using quantitative differences in fluorescence intensity | SMITHKLINE BEECHAM CORPORATION (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0219309-B1 | METHODS AND REAGENTS FOR PERFORMING ANALYSES OF SUBPOPULATIONS OF PARTICLES | SMITHKLINE BEECHAM CORPORATION (US) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159611-A1 | SMALL MOLECULE ADAPTER REGULATED, TARGET SPECIFIC CHIMERIC ANTIGEN RECEPTOR BEARING T CELLS (SMART CARS) | CD47, CD4, CD2 | SNCA 4704/4885HDAC3 3764/4885HDAC4 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.